TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $46,000 | +17.9% | 34,166 | -1.7% | 0.00% | – |
Q4 2018 | $39,000 | -59.8% | 34,768 | -0.8% | 0.00% | – |
Q3 2018 | $97,000 | -19.2% | 35,035 | +4.3% | 0.00% | – |
Q2 2018 | $120,000 | +18.8% | 33,604 | +2.2% | 0.00% | – |
Q1 2018 | $101,000 | -53.2% | 32,892 | -4.1% | 0.00% | -100.0% |
Q4 2017 | $216,000 | -6.5% | 34,298 | +1.4% | 0.00% | 0.0% |
Q3 2017 | $231,000 | +38.3% | 33,826 | +44.1% | 0.00% | 0.0% |
Q2 2017 | $167,000 | -18.9% | 23,481 | +4.9% | 0.00% | 0.0% |
Q1 2017 | $206,000 | +145.2% | 22,390 | +7.1% | 0.00% | – |
Q4 2016 | $84,000 | -99.9% | 20,904 | -0.3% | 0.00% | – |
Q3 2016 | $80,269,000 | -10.8% | 20,958 | +0.2% | 0.00% | – |
Q2 2016 | $89,982,000 | -13.5% | 20,926 | -7.0% | 0.00% | – |
Q1 2016 | $104,000,000 | -53.8% | 22,495 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $225,000,000 | +133828.6% | 22,495 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $168,000 | -100.0% | 22,532 | +0.1% | 0.00% | -75.0% |
Q2 2015 | $1,067,732,000 | +64.3% | 22,507 | +26.9% | 0.00% | +33.3% |
Q1 2015 | $649,774,000 | -7.7% | 17,734 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $704,217,000 | +129.0% | 17,734 | +15.1% | 0.00% | +200.0% |
Q3 2014 | $307,469,000 | +47.8% | 15,412 | -0.1% | 0.00% | 0.0% |
Q2 2014 | $208,056,000 | +100.3% | 15,423 | +61.7% | 0.00% | – |
Q1 2014 | $103,869,000 | -17.5% | 9,538 | +2.5% | 0.00% | -100.0% |
Q4 2013 | $125,858,000 | +43.2% | 9,309 | +20.6% | 0.00% | – |
Q3 2013 | $87,865,000 | – | 7,721 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |